UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000063486
Receipt number R000072661
Scientific Title Effects of Midwife-Led Soft Birth Canal Maturation Care for Pregnant Women at 37 Weeks of Gestation or Later on Birth Outcomes
Date of disclosure of the study information 2026/11/01
Last modified on 2026/11/01 11:02:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of Midwife-Led Soft Birth Canal Maturation Care for Pregnant Women at 37 Weeks of Gestation or Later on Birth Outcomes

Acronym

Effects of Midwife-Led Soft Birth Canal Maturation Care for Pregnant Women at 37 Weeks of Gestation or Later on Birth Outcomes

Scientific Title

Effects of Midwife-Led Soft Birth Canal Maturation Care for Pregnant Women at 37 Weeks of Gestation or Later on Birth Outcomes

Scientific Title:Acronym

Effects of Midwife-Led Soft Birth Canal Maturation Care for Pregnant Women at 37 Weeks of Gestation or Later on Birth Outcomes

Region

Japan


Condition

Condition

Longitudinal Changes in Soft Birth Canal Maturation in Pregnant Women at 37 Weeks of Gestation or Later

Classification by specialty

Obstetrics and Gynecology Nursing

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effects of midwife-led soft birth canal maturation care for pregnant women at 37 weeks of gestation or later on birth outcomes.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Longitudinal changes in cervical ripening over time.

Key secondary outcomes

Association between the final Bishop score and birth outcomes.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

In the intervention group, midwife-led soft birth canal maturation care will be provided at 37, 38, 39, and 40 weeks of gestation.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

45 years-old >=

Gender

Female

Key inclusion criteria

A total of 30 pregnant women will be enrolled from among those receiving care at the study site during the study period who have singleton pregnancies, uncomplicated pregnancies, and planned vaginal births, provided that their physicians consider them eligible for participation and they provide informed consent.

Participants must meet all the following criteria:
1.Women aged 20 years or older at the time of obtaining informed consent.
2.Women with uncomplicated pregnancies who are planning vaginal birth.
3.Women who wish to have a spontaneous vaginal birth.
4.Women who have received a sufficient explanation of the study, have fully understood its contents, and have provided written informed consent voluntarily.
5.Women deemed eligible for participation by their attending physician.

Key exclusion criteria

1.Women with pregnancy complications or abnormalities, including multiple pregnancies, breech presentation, or placenta previa.
2.Women scheduled for cesarean delivery.
3.Pregnant women younger than 20 years of age.
4.Women with known allergies to any component of the oils used in the study or to food-derived ingredients.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name SHOKO
Middle name
Last name KKATO

Organization

Miyazaki Prefectural Nursing University

Division name

Doctoral Program, Graduate School of Nursing, Miyazaki Prefectural Nursing University

Zip code

880-0929

Address

3-5-1 Manabino, Miyazaki City, Miyazaki Prefecture, Japan

TEL

0985-59-7700

Email

d16001@mpu.ac.jp


Public contact

Name of contact person

1st name SHOKO
Middle name
Last name KATO

Organization

Miyazaki Prefectural Nursing University

Division name

Graduate School of Nursing, Miyazaki Prefectural Nursing University

Zip code

880-0929

Address

3-5-1 Manabino, Miyazaki City, Miyazaki Prefecture, Japan

TEL

09044201738

Homepage URL


Email

d16001@mpu.ac.jp


Sponsor or person

Institute

Miyazaki Prefectural Nursing University

Institute

Department

Personal name

SHOKO KATO


Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Miyazaki Prefectural Nursing University

Address

3-5-1 Manabino, Miyazaki City, Miyazaki Prefecture, Japan

Tel

0985-59-7700

Email

d16001@mpu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京慈恵会医科大学附属病院 母子医療センター


Other administrative information

Date of disclosure of the study information

2026 Year 11 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2026 Year 10 Month 10 Day

Date of IRB

2026 Year 08 Month 31 Day

Anticipated trial start date

2026 Year 11 Month 01 Day

Last follow-up date

2028 Year 03 Month 31 Day

Date of closure to data entry

2028 Year 03 Month 31 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 11 Month 01 Day

Last modified on

2026 Year 11 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072661